nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—melanoma	0.379	0.727	CbGaD
Rosiglitazone—ALB—melanoma	0.143	0.273	CbGaD
Rosiglitazone—ALB—Vemurafenib—melanoma	0.0848	0.302	CbGbCtD
Rosiglitazone—CYP1A2—Carmustine—melanoma	0.0642	0.229	CbGbCtD
Rosiglitazone—CYP1A2—Vemurafenib—melanoma	0.0507	0.181	CbGbCtD
Rosiglitazone—CYP2D6—Vemurafenib—melanoma	0.0418	0.149	CbGbCtD
Rosiglitazone—CYP1A2—Dacarbazine—melanoma	0.0389	0.139	CbGbCtD
Rosiglitazone—PPARG—dermis—melanoma	0.0061	0.172	CbGeAlD
Rosiglitazone—PPARG—leg—melanoma	0.00402	0.114	CbGeAlD
Rosiglitazone—PPARG—hindlimb—melanoma	0.00359	0.102	CbGeAlD
Rosiglitazone—PPARG—appendage—melanoma	0.00308	0.0871	CbGeAlD
Rosiglitazone—ACSL4—eye—melanoma	0.00203	0.0574	CbGeAlD
Rosiglitazone—ACSL4—retina—melanoma	0.00201	0.0569	CbGeAlD
Rosiglitazone—Pioglitazone—PPARG—melanoma	0.0019	1	CrCbGaD
Rosiglitazone—PPARG—endothelium—melanoma	0.00186	0.0526	CbGeAlD
Rosiglitazone—PPARG—blood vessel—melanoma	0.00172	0.0485	CbGeAlD
Rosiglitazone—ACSL4—mammalian vulva—melanoma	0.00161	0.0455	CbGeAlD
Rosiglitazone—Visual acuity reduced—Temozolomide—melanoma	0.0015	0.0224	CcSEcCtD
Rosiglitazone—PPARG—neck—melanoma	0.00123	0.0347	CbGeAlD
Rosiglitazone—ACSL4—head—melanoma	0.00115	0.0326	CbGeAlD
Rosiglitazone—PTGS1—endothelium—melanoma	0.000995	0.0281	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Temozolomide—melanoma	0.000981	0.0147	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000968	0.0145	CcSEcCtD
Rosiglitazone—Hepatic enzyme increased—Temozolomide—melanoma	0.000944	0.0141	CcSEcCtD
Rosiglitazone—PTGS1—blood vessel—melanoma	0.000917	0.0259	CbGeAlD
Rosiglitazone—Oedema peripheral—Vemurafenib—melanoma	0.000864	0.0129	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Vemurafenib—melanoma	0.000862	0.0129	CcSEcCtD
Rosiglitazone—Erythema multiforme—Vemurafenib—melanoma	0.000829	0.0124	CcSEcCtD
Rosiglitazone—Eye disorder—Vemurafenib—melanoma	0.000819	0.0123	CcSEcCtD
Rosiglitazone—Cardiac disorder—Vemurafenib—melanoma	0.000814	0.0122	CcSEcCtD
Rosiglitazone—ACSL4—lymph node—melanoma	0.000807	0.0228	CbGeAlD
Rosiglitazone—Hepatic failure—Dactinomycin—melanoma	0.000797	0.0119	CcSEcCtD
Rosiglitazone—PPARG—skin of body—melanoma	0.000794	0.0225	CbGeAlD
Rosiglitazone—Cerebrovascular accident—Bleomycin—melanoma	0.000784	0.0117	CcSEcCtD
Rosiglitazone—Pleural effusion—Docetaxel—melanoma	0.000775	0.0116	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Carmustine—melanoma	0.000771	0.0115	CcSEcCtD
Rosiglitazone—Malnutrition—Vemurafenib—melanoma	0.000763	0.0114	CcSEcCtD
Rosiglitazone—Back pain—Vemurafenib—melanoma	0.000738	0.011	CcSEcCtD
Rosiglitazone—Myocardial ischaemia—Docetaxel—melanoma	0.000738	0.011	CcSEcCtD
Rosiglitazone—PPARG—mammalian vulva—melanoma	0.000725	0.0205	CbGeAlD
Rosiglitazone—Hepatic failure—Temozolomide—melanoma	0.000721	0.0108	CcSEcCtD
Rosiglitazone—Hyperbilirubinaemia—Docetaxel—melanoma	0.000653	0.00976	CcSEcCtD
Rosiglitazone—Arthralgia—Vemurafenib—melanoma	0.00065	0.00972	CcSEcCtD
Rosiglitazone—Myalgia—Vemurafenib—melanoma	0.00065	0.00972	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Vemurafenib—melanoma	0.000623	0.00932	CcSEcCtD
Rosiglitazone—Infection—Vemurafenib—melanoma	0.000619	0.00926	CcSEcCtD
Rosiglitazone—Nervous system disorder—Vemurafenib—melanoma	0.000611	0.00914	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Bleomycin—melanoma	0.000583	0.00873	CcSEcCtD
Rosiglitazone—Myocardial infarction—Bleomycin—melanoma	0.00058	0.00868	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000568	0.00849	CcSEcCtD
Rosiglitazone—Fluid retention—Docetaxel—melanoma	0.000563	0.00843	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000547	0.00819	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Vemurafenib—melanoma	0.000538	0.00805	CcSEcCtD
Rosiglitazone—Fatigue—Vemurafenib—melanoma	0.000537	0.00803	CcSEcCtD
Rosiglitazone—Constipation—Vemurafenib—melanoma	0.000533	0.00797	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Docetaxel—melanoma	0.000528	0.0079	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Carmustine—melanoma	0.000523	0.00782	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Temozolomide—melanoma	0.00052	0.00778	CcSEcCtD
Rosiglitazone—PPARG—head—melanoma	0.000518	0.0147	CbGeAlD
Rosiglitazone—Weight increased—Temozolomide—melanoma	0.00051	0.00762	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Temozolomide—melanoma	0.000505	0.00755	CcSEcCtD
Rosiglitazone—Hepatitis—Dactinomycin—melanoma	0.000495	0.00741	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000495	0.0074	CcSEcCtD
Rosiglitazone—Hepatic failure—Docetaxel—melanoma	0.000479	0.00717	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Docetaxel—melanoma	0.000475	0.00711	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Temozolomide—melanoma	0.000472	0.00706	CcSEcCtD
Rosiglitazone—Erythema multiforme—Dactinomycin—melanoma	0.000468	0.00701	CcSEcCtD
Rosiglitazone—Sinusitis—Temozolomide—melanoma	0.000468	0.00701	CcSEcCtD
Rosiglitazone—Oedema peripheral—Carmustine—melanoma	0.000457	0.00683	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Carmustine—melanoma	0.000456	0.00682	CcSEcCtD
Rosiglitazone—Hepatitis—Temozolomide—melanoma	0.000448	0.0067	CcSEcCtD
Rosiglitazone—Asthenia—Vemurafenib—melanoma	0.000447	0.00669	CcSEcCtD
Rosiglitazone—Oedema peripheral—Temozolomide—melanoma	0.000441	0.0066	CcSEcCtD
Rosiglitazone—Cardiac failure—Docetaxel—melanoma	0.000441	0.0066	CcSEcCtD
Rosiglitazone—Pruritus—Vemurafenib—melanoma	0.000441	0.00659	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Temozolomide—melanoma	0.00044	0.00659	CcSEcCtD
Rosiglitazone—Eye disorder—Carmustine—melanoma	0.000433	0.00648	CcSEcCtD
Rosiglitazone—Anaemia—Bleomycin—melanoma	0.000427	0.00639	CcSEcCtD
Rosiglitazone—Diarrhoea—Vemurafenib—melanoma	0.000426	0.00638	CcSEcCtD
Rosiglitazone—PTGS1—skin of body—melanoma	0.000425	0.012	CbGeAlD
Rosiglitazone—Erythema multiforme—Temozolomide—melanoma	0.000424	0.00634	CcSEcCtD
Rosiglitazone—Eye disorder—Temozolomide—melanoma	0.000419	0.00626	CcSEcCtD
Rosiglitazone—Cardiac disorder—Temozolomide—melanoma	0.000416	0.00622	CcSEcCtD
Rosiglitazone—Leukopenia—Bleomycin—melanoma	0.000414	0.00619	CcSEcCtD
Rosiglitazone—Dizziness—Vemurafenib—melanoma	0.000412	0.00616	CcSEcCtD
Rosiglitazone—Immune system disorder—Temozolomide—melanoma	0.000405	0.00605	CcSEcCtD
Rosiglitazone—Malnutrition—Carmustine—melanoma	0.000404	0.00604	CcSEcCtD
Rosiglitazone—Anaemia—Dactinomycin—melanoma	0.000399	0.00596	CcSEcCtD
Rosiglitazone—Myalgia—Bleomycin—melanoma	0.000394	0.00589	CcSEcCtD
Rosiglitazone—Rash—Vemurafenib—melanoma	0.000393	0.00588	CcSEcCtD
Rosiglitazone—Dermatitis—Vemurafenib—melanoma	0.000392	0.00587	CcSEcCtD
Rosiglitazone—Back pain—Carmustine—melanoma	0.00039	0.00584	CcSEcCtD
Rosiglitazone—Headache—Vemurafenib—melanoma	0.00039	0.00584	CcSEcCtD
Rosiglitazone—Malnutrition—Temozolomide—melanoma	0.00039	0.00584	CcSEcCtD
Rosiglitazone—PTGS1—mammalian vulva—melanoma	0.000387	0.0109	CbGeAlD
Rosiglitazone—Leukopenia—Dactinomycin—melanoma	0.000386	0.00578	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Docetaxel—melanoma	0.000385	0.00576	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Bleomycin—melanoma	0.000377	0.00565	CcSEcCtD
Rosiglitazone—Oedema—Bleomycin—melanoma	0.000377	0.00565	CcSEcCtD
Rosiglitazone—Back pain—Temozolomide—melanoma	0.000377	0.00564	CcSEcCtD
Rosiglitazone—Infection—Bleomycin—melanoma	0.000375	0.00561	CcSEcCtD
Rosiglitazone—Anaemia—Carmustine—melanoma	0.000373	0.00558	CcSEcCtD
Rosiglitazone—Nausea—Vemurafenib—melanoma	0.00037	0.00554	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Bleomycin—melanoma	0.00037	0.00553	CcSEcCtD
Rosiglitazone—Myalgia—Dactinomycin—melanoma	0.000367	0.00549	CcSEcCtD
Rosiglitazone—PPARG—lymph node—melanoma	0.000363	0.0103	CbGeAlD
Rosiglitazone—Leukopenia—Carmustine—melanoma	0.000361	0.00541	CcSEcCtD
Rosiglitazone—Anaemia—Temozolomide—melanoma	0.000361	0.00539	CcSEcCtD
Rosiglitazone—Angioedema—Temozolomide—melanoma	0.000356	0.00533	CcSEcCtD
Rosiglitazone—Oedema—Dactinomycin—melanoma	0.000352	0.00527	CcSEcCtD
Rosiglitazone—Infection—Dactinomycin—melanoma	0.00035	0.00523	CcSEcCtD
Rosiglitazone—Leukopenia—Temozolomide—melanoma	0.000349	0.00522	CcSEcCtD
Rosiglitazone—Hypertension—Carmustine—melanoma	0.000349	0.00521	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Dactinomycin—melanoma	0.000345	0.00516	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000344	0.00514	CcSEcCtD
Rosiglitazone—Myalgia—Carmustine—melanoma	0.000344	0.00514	CcSEcCtD
Rosiglitazone—ALB—lymph node—melanoma	0.00034	0.00962	CbGeAlD
Rosiglitazone—Weight increased—Docetaxel—melanoma	0.000339	0.00507	CcSEcCtD
Rosiglitazone—Hypertension—Temozolomide—melanoma	0.000337	0.00504	CcSEcCtD
Rosiglitazone—Arthralgia—Temozolomide—melanoma	0.000332	0.00497	CcSEcCtD
Rosiglitazone—Myalgia—Temozolomide—melanoma	0.000332	0.00497	CcSEcCtD
Rosiglitazone—Oedema—Carmustine—melanoma	0.000329	0.00493	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000329	0.00492	CcSEcCtD
Rosiglitazone—Infection—Carmustine—melanoma	0.000327	0.0049	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Docetaxel—melanoma	0.000327	0.0049	CcSEcCtD
Rosiglitazone—Myocardial infarction—Docetaxel—melanoma	0.000325	0.00487	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Carmustine—melanoma	0.000323	0.00483	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000321	0.0048	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Temozolomide—melanoma	0.000318	0.00476	CcSEcCtD
Rosiglitazone—Oedema—Temozolomide—melanoma	0.000318	0.00476	CcSEcCtD
Rosiglitazone—Infection—Temozolomide—melanoma	0.000316	0.00473	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Docetaxel—melanoma	0.000314	0.0047	CcSEcCtD
Rosiglitazone—Nervous system disorder—Temozolomide—melanoma	0.000312	0.00467	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Temozolomide—melanoma	0.000312	0.00466	CcSEcCtD
Rosiglitazone—Fatigue—Dactinomycin—melanoma	0.000304	0.00454	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Carmustine—melanoma	0.0003	0.00449	CcSEcCtD
Rosiglitazone—Urticaria—Bleomycin—melanoma	0.0003	0.00449	CcSEcCtD
Rosiglitazone—Hepatitis—Docetaxel—melanoma	0.000298	0.00446	CcSEcCtD
Rosiglitazone—Oedema peripheral—Docetaxel—melanoma	0.000294	0.00439	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Docetaxel—melanoma	0.000293	0.00438	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00029	0.00434	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Carmustine—melanoma	0.000284	0.00425	CcSEcCtD
Rosiglitazone—Erythema multiforme—Docetaxel—melanoma	0.000282	0.00422	CcSEcCtD
Rosiglitazone—Constipation—Carmustine—melanoma	0.000282	0.00421	CcSEcCtD
Rosiglitazone—Eye disorder—Docetaxel—melanoma	0.000279	0.00417	CcSEcCtD
Rosiglitazone—PTGS1—head—melanoma	0.000277	0.00783	CbGeAlD
Rosiglitazone—Cardiac disorder—Docetaxel—melanoma	0.000277	0.00414	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Temozolomide—melanoma	0.000275	0.00411	CcSEcCtD
Rosiglitazone—Fatigue—Temozolomide—melanoma	0.000275	0.00411	CcSEcCtD
Rosiglitazone—Constipation—Temozolomide—melanoma	0.000272	0.00407	CcSEcCtD
Rosiglitazone—Asthenia—Bleomycin—melanoma	0.000271	0.00405	CcSEcCtD
Rosiglitazone—Immune system disorder—Docetaxel—melanoma	0.000269	0.00403	CcSEcCtD
Rosiglitazone—Pruritus—Bleomycin—melanoma	0.000267	0.00399	CcSEcCtD
Rosiglitazone—Malnutrition—Docetaxel—melanoma	0.000259	0.00388	CcSEcCtD
Rosiglitazone—Urticaria—Temozolomide—melanoma	0.000253	0.00378	CcSEcCtD
Rosiglitazone—Asthenia—Dactinomycin—melanoma	0.000253	0.00378	CcSEcCtD
Rosiglitazone—Back pain—Docetaxel—melanoma	0.000251	0.00375	CcSEcCtD
Rosiglitazone—Diarrhoea—Dactinomycin—melanoma	0.000241	0.0036	CcSEcCtD
Rosiglitazone—Anaemia—Docetaxel—melanoma	0.00024	0.00359	CcSEcCtD
Rosiglitazone—Rash—Bleomycin—melanoma	0.000238	0.00356	CcSEcCtD
Rosiglitazone—Dermatitis—Bleomycin—melanoma	0.000238	0.00356	CcSEcCtD
Rosiglitazone—Asthenia—Carmustine—melanoma	0.000236	0.00354	CcSEcCtD
Rosiglitazone—Leukopenia—Docetaxel—melanoma	0.000232	0.00347	CcSEcCtD
Rosiglitazone—Asthenia—Temozolomide—melanoma	0.000228	0.00342	CcSEcCtD
Rosiglitazone—CYP2D6—head—melanoma	0.000228	0.00644	CbGeAlD
Rosiglitazone—Diarrhoea—Carmustine—melanoma	0.000225	0.00337	CcSEcCtD
Rosiglitazone—Pruritus—Temozolomide—melanoma	0.000225	0.00337	CcSEcCtD
Rosiglitazone—Nausea—Bleomycin—melanoma	0.000224	0.00335	CcSEcCtD
Rosiglitazone—Hypertension—Docetaxel—melanoma	0.000224	0.00335	CcSEcCtD
Rosiglitazone—Rash—Dactinomycin—melanoma	0.000222	0.00332	CcSEcCtD
Rosiglitazone—Arthralgia—Docetaxel—melanoma	0.000221	0.0033	CcSEcCtD
Rosiglitazone—Myalgia—Docetaxel—melanoma	0.000221	0.0033	CcSEcCtD
Rosiglitazone—Dizziness—Carmustine—melanoma	0.000218	0.00326	CcSEcCtD
Rosiglitazone—Diarrhoea—Temozolomide—melanoma	0.000218	0.00326	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Docetaxel—melanoma	0.000212	0.00317	CcSEcCtD
Rosiglitazone—Oedema—Docetaxel—melanoma	0.000212	0.00317	CcSEcCtD
Rosiglitazone—Dizziness—Temozolomide—melanoma	0.000211	0.00315	CcSEcCtD
Rosiglitazone—Infection—Docetaxel—melanoma	0.00021	0.00315	CcSEcCtD
Rosiglitazone—Nausea—Dactinomycin—melanoma	0.000209	0.00313	CcSEcCtD
Rosiglitazone—Rash—Carmustine—melanoma	0.000208	0.00311	CcSEcCtD
Rosiglitazone—Nervous system disorder—Docetaxel—melanoma	0.000208	0.00311	CcSEcCtD
Rosiglitazone—Dermatitis—Carmustine—melanoma	0.000208	0.0031	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Docetaxel—melanoma	0.000207	0.0031	CcSEcCtD
Rosiglitazone—Headache—Carmustine—melanoma	0.000206	0.00309	CcSEcCtD
Rosiglitazone—Rash—Temozolomide—melanoma	0.000201	0.003	CcSEcCtD
Rosiglitazone—Dermatitis—Temozolomide—melanoma	0.000201	0.003	CcSEcCtD
Rosiglitazone—Headache—Temozolomide—melanoma	0.000199	0.00298	CcSEcCtD
Rosiglitazone—Nausea—Carmustine—melanoma	0.000196	0.00293	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—melanoma	0.000194	0.00548	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000193	0.00289	CcSEcCtD
Rosiglitazone—Nausea—Temozolomide—melanoma	0.000189	0.00283	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Docetaxel—melanoma	0.000183	0.00273	CcSEcCtD
Rosiglitazone—Fatigue—Docetaxel—melanoma	0.000183	0.00273	CcSEcCtD
Rosiglitazone—Constipation—Docetaxel—melanoma	0.000181	0.00271	CcSEcCtD
Rosiglitazone—Asthenia—Docetaxel—melanoma	0.000152	0.00227	CcSEcCtD
Rosiglitazone—Pruritus—Docetaxel—melanoma	0.00015	0.00224	CcSEcCtD
Rosiglitazone—Diarrhoea—Docetaxel—melanoma	0.000145	0.00217	CcSEcCtD
Rosiglitazone—Dizziness—Docetaxel—melanoma	0.00014	0.00209	CcSEcCtD
Rosiglitazone—Rash—Docetaxel—melanoma	0.000134	0.002	CcSEcCtD
Rosiglitazone—Dermatitis—Docetaxel—melanoma	0.000133	0.002	CcSEcCtD
Rosiglitazone—Headache—Docetaxel—melanoma	0.000133	0.00198	CcSEcCtD
Rosiglitazone—Nausea—Docetaxel—melanoma	0.000126	0.00188	CcSEcCtD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.24e-05	0.000132	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GNAQ—melanoma	1.23e-05	0.000131	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD44—melanoma	1.23e-05	0.000131	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—FN1—melanoma	1.22e-05	0.000131	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	1.22e-05	0.00013	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPAM—melanoma	1.22e-05	0.00013	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS2—melanoma	1.21e-05	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPAM—melanoma	1.21e-05	0.000129	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CYP1B1—melanoma	1.18e-05	0.000126	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CG—melanoma	1.17e-05	0.000125	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—EGF—melanoma	1.16e-05	0.000124	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—melanoma	1.15e-05	0.000123	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HRAS—melanoma	1.15e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PHGDH—melanoma	1.15e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LUM—melanoma	1.15e-05	0.000122	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—VCAN—melanoma	1.13e-05	0.000121	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—VCAN—melanoma	1.13e-05	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLA2G6—melanoma	1.13e-05	0.00012	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HPSE—melanoma	1.12e-05	0.00012	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.11e-05	0.000118	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CUBN—melanoma	1.1e-05	0.000118	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.1e-05	0.000117	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—melanoma	1.1e-05	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.07e-05	0.000114	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IGF1—melanoma	1.07e-05	0.000114	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.07e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDHD—melanoma	1.07e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BSG—melanoma	1.07e-05	0.000114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CSPG4—melanoma	1.07e-05	0.000114	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	1.06e-05	0.000113	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PRKCA—melanoma	1.06e-05	0.000113	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CG—melanoma	1.06e-05	0.000113	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ERCC2—melanoma	1.05e-05	0.000112	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G6—melanoma	1.04e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.04e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPAM—melanoma	1.03e-05	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CD—melanoma	1.03e-05	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.03e-05	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G6—melanoma	1.03e-05	0.00011	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—melanoma	1.03e-05	0.000109	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—melanoma	1.01e-05	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—VCAN—melanoma	1.01e-05	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—melanoma	9.71e-06	0.000103	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.58e-06	0.000102	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP17A1—melanoma	9.57e-06	0.000102	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP17A1—melanoma	9.51e-06	0.000101	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PRKCA—melanoma	9.45e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.43e-06	0.000101	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.38e-06	0.0001	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ERCC2—melanoma	9.37e-06	9.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	9.31e-06	9.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—VCAN—melanoma	9.31e-06	9.92e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CD—melanoma	9.29e-06	9.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.25e-06	9.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—VCAN—melanoma	9.23e-06	9.84e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—melanoma	9.17e-06	9.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNA11—melanoma	9.03e-06	9.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNA11—melanoma	8.98e-06	9.58e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CB—melanoma	8.98e-06	9.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PRKCA—melanoma	8.93e-06	9.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ERCC2—melanoma	8.86e-06	9.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—FASN—melanoma	8.84e-06	9.42e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—FASN—melanoma	8.79e-06	9.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G6—melanoma	8.78e-06	9.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	8.73e-06	9.31e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	8.72e-06	9.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC5A5—melanoma	8.7e-06	9.27e-05	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	8.68e-06	9.25e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC5A5—melanoma	8.65e-06	9.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP17A1—melanoma	8.54e-06	9.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.43e-06	8.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.42e-06	8.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNAQ—melanoma	8.4e-06	8.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD44—melanoma	8.4e-06	8.95e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNAQ—melanoma	8.35e-06	8.9e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD44—melanoma	8.35e-06	8.9e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CG—melanoma	8.32e-06	8.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.31e-06	8.86e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IL2—melanoma	8.25e-06	8.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.22e-06	8.77e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.18e-06	8.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.15e-06	8.69e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.1e-06	8.64e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CB—melanoma	8.09e-06	8.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNA11—melanoma	8.06e-06	8.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1B1—melanoma	8.05e-06	8.58e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—melanoma	8.03e-06	8.56e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—melanoma	8.02e-06	8.55e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1B1—melanoma	8.01e-06	8.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—FASN—melanoma	7.89e-06	8.41e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—VCAN—melanoma	7.89e-06	8.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP17A1—melanoma	7.85e-06	8.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP17A1—melanoma	7.79e-06	8.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC5A5—melanoma	7.76e-06	8.27e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.76e-06	8.27e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MAPK3—melanoma	7.69e-06	8.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.68e-06	8.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.58e-06	8.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNAQ—melanoma	7.5e-06	7.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD44—melanoma	7.5e-06	7.99e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—melanoma	7.47e-06	7.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.46e-06	7.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNA11—melanoma	7.42e-06	7.91e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—melanoma	7.4e-06	7.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNA11—melanoma	7.35e-06	7.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.34e-06	7.83e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—melanoma	7.31e-06	7.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.27e-06	7.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—FASN—melanoma	7.26e-06	7.74e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—melanoma	7.22e-06	7.7e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.2e-06	7.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—FASN—melanoma	7.19e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1B1—melanoma	7.19e-06	7.66e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—melanoma	7.14e-06	7.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A5—melanoma	7.14e-06	7.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.11e-06	7.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A5—melanoma	7.08e-06	7.54e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.07e-06	7.53e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—melanoma	7.01e-06	7.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—melanoma	7e-06	7.46e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—melanoma	6.99e-06	7.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NRAS—melanoma	6.92e-06	7.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD44—melanoma	6.89e-06	7.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNAQ—melanoma	6.89e-06	7.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNAQ—melanoma	6.83e-06	7.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD44—melanoma	6.83e-06	7.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—melanoma	6.75e-06	7.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.69e-06	7.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP17A1—melanoma	6.65e-06	7.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.63e-06	7.07e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—melanoma	6.63e-06	7.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—melanoma	6.63e-06	7.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1B1—melanoma	6.61e-06	7.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—melanoma	6.59e-06	7.03e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.56e-06	7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1B1—melanoma	6.55e-06	6.99e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—melanoma	6.5e-06	6.93e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.48e-06	6.91e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—melanoma	6.42e-06	6.85e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—melanoma	6.37e-06	6.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.34e-06	6.76e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—melanoma	6.32e-06	6.73e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK1—melanoma	6.31e-06	6.73e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNA11—melanoma	6.28e-06	6.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—melanoma	6.15e-06	6.56e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FASN—melanoma	6.15e-06	6.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PRKCA—melanoma	6.1e-06	6.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—melanoma	6.07e-06	6.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PRKCA—melanoma	6.07e-06	6.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ERCC2—melanoma	6.05e-06	6.45e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A5—melanoma	6.05e-06	6.45e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ERCC2—melanoma	6.02e-06	6.41e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—melanoma	5.96e-06	6.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—melanoma	5.92e-06	6.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNAQ—melanoma	5.84e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD44—melanoma	5.84e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.78e-06	6.17e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.72e-06	6.1e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—melanoma	5.67e-06	6.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.67e-06	6.04e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—melanoma	5.62e-06	5.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1B1—melanoma	5.6e-06	5.97e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—melanoma	5.51e-06	5.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—melanoma	5.48e-06	5.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PRKCA—melanoma	5.45e-06	5.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—melanoma	5.44e-06	5.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ERCC2—melanoma	5.4e-06	5.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—melanoma	5.4e-06	5.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—melanoma	5.36e-06	5.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—melanoma	5.31e-06	5.66e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—melanoma	5.3e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—melanoma	5.18e-06	5.53e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—melanoma	5.07e-06	5.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.01e-06	5.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PRKCA—melanoma	5.01e-06	5.34e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.98e-06	5.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ERCC2—melanoma	4.97e-06	5.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PRKCA—melanoma	4.97e-06	5.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.94e-06	5.27e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—melanoma	4.93e-06	5.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ERCC2—melanoma	4.93e-06	5.25e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—melanoma	4.9e-06	5.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—melanoma	4.78e-06	5.1e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—melanoma	4.75e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—melanoma	4.63e-06	4.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—melanoma	4.61e-06	4.92e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—melanoma	4.61e-06	4.92e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—melanoma	4.59e-06	4.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.47e-06	4.77e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—melanoma	4.47e-06	4.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—melanoma	4.27e-06	4.55e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PRKCA—melanoma	4.24e-06	4.52e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ERCC2—melanoma	4.21e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—melanoma	4.2e-06	4.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—melanoma	4.18e-06	4.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—melanoma	4.15e-06	4.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—melanoma	4.12e-06	4.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.08e-06	4.35e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—melanoma	4.03e-06	4.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—melanoma	3.92e-06	4.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—melanoma	3.89e-06	4.15e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—melanoma	3.89e-06	4.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—melanoma	3.79e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—melanoma	3.75e-06	4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—melanoma	3.75e-06	4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—melanoma	3.7e-06	3.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—melanoma	3.66e-06	3.9e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—melanoma	3.64e-06	3.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—melanoma	3.63e-06	3.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—melanoma	3.61e-06	3.85e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.49e-06	3.72e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—melanoma	3.46e-06	3.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—melanoma	3.45e-06	3.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—melanoma	3.42e-06	3.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—melanoma	3.41e-06	3.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—melanoma	3.38e-06	3.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—melanoma	3.32e-06	3.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—melanoma	3.27e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—melanoma	3.27e-06	3.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—melanoma	3.24e-06	3.45e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—melanoma	3.21e-06	3.42e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—melanoma	3.17e-06	3.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—melanoma	3.16e-06	3.37e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—melanoma	3.15e-06	3.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—melanoma	3.01e-06	3.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—melanoma	2.98e-06	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—melanoma	2.98e-06	3.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—melanoma	2.95e-06	3.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—melanoma	2.92e-06	3.12e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—melanoma	2.88e-06	3.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—melanoma	2.82e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—melanoma	2.82e-06	3.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—melanoma	2.67e-06	2.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—melanoma	2.6e-06	2.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—melanoma	2.58e-06	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—melanoma	2.55e-06	2.72e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—melanoma	2.52e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—melanoma	2.23e-06	2.38e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—melanoma	2.22e-06	2.37e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—melanoma	2.2e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—melanoma	1.99e-06	2.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—melanoma	1.83e-06	1.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—melanoma	1.82e-06	1.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—melanoma	1.82e-06	1.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—melanoma	1.81e-06	1.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—melanoma	1.63e-06	1.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—melanoma	1.55e-06	1.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—melanoma	1.5e-06	1.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—melanoma	1.48e-06	1.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—melanoma	1.27e-06	1.35e-05	CbGpPWpGaD
